Volume : 09, Issue : 02, February – 2022

Title:

23.SYNTHESIS AND BIOLOGICAL EVALUATION OF 3-{4-[5-(SUBSTITUTED PHENYL)ISOXAZOL-3-YL]PHENYL}-2-(4-HYDROXYPHENYL)-1,3-THIAZOLIDIN-4-ONE

Authors :

Nital N. Patel, Pankaj S. Patel*

Abstract :

Heterocyclic Compounds have so far been synthesized mainly due to the wide range of biological activities. Isoxazoles plays an important role in biological field. From these reviews we synthesized a new series of 3-{4-[5-(substititedphenyll) isoxazol-3-yl]phenyl}-2-(4-hydroxyphenyl)-1,3-thiazolidin-4-one derived from 3-{4-[3-(substitutedphenyl)prop-2-enoyl]phenyl}-2-(4-hydroxyphenyl)-1,3-thiazolidin-4-one and hydroxylamine hydrochloride. The title compounds were characterized by element analysis, IR, NMR and spectral data. All the compounds were tested for their antibacterial and antifungal activities by Cup Borer method.
Keywords: Isoxazoles, IR, NMR, Cup Borer method.

Cite This Article:

Please cite this article in press Pankaj S. Patel et al, “Synthesis And Biological Evaluation Of 3-{4-[5-(Substituted Phenyl)Isoxazol-3-Yl]Phenyl}-2-(4-Hydroxyphenyl)-1,3-Thiazolidin-4-One”., Indo Am. J. P. Sci, 2022; 09(2).

Number of Downloads : 10

References:

1.Karthikeyan K, Veenus Seelan T, Lalitha KG, Perumal PT. Synthesis and antinociceptive activity of pyrazolyl isoxazolines and pyrazolyl isoxazoles. Bioorg Med Chem Lett, 2009; 19: 3370–3373.
2.Rajanarendar E, Rama Krishna S, Nagaraju D, Govardhan Reddy K, Kishore B, Reddy YN. Environmentally benign synthesis, molecular properties prediction and anti-inflammatory activity of novel isoxazolo[5,4-d]isoxazol-3-yl-aryl-methanones via vinylogous Henry nitroaldol adducts as synthons. Bioorg Med Chem Lett, 2015; 25:1630–1634
3.Kumbhare RM, Kosurkar UB, Janaki Ramaiah M, Dadmal TL, Pushpavalli SNCVL, Pal-Bhadra M. Synthesis and biological evaluation of novel triazoles and isoxazoles linked 2-phenyl benzothiazole as potential anticancer agents. Bioorg Med Chem Lett, 2012; 22: 5424–5427
4.Basha SS, Divya K, Padmaja A, Padmavathi V. Synthesis and antimicrobial activity of thiazolyl pyrazoles and isoxazoles. Res Chem Intermed, 2015; 41:10067–10083
5.Lee YS, Park SM, Kim BH. Synthesis of 5-isoxazol-5-yl-2’-deoxyuridines exhibiting antiviral activity against HSV and several RNA viruses. Bioorg Med Chem Lett, 2009; 19: 1126–1128
6.Frølund B, Jensen LS, Storustovu SI, Stensbøl TB, Ebert B, Kehler J, Krogsgaard-Larsen P, Liljefors T. 4-Aryl-5-(4-piperidyl)- 3-isoxazolol GABA A antagonists: synthesis, pharmacology, and structure−activity relationships. J Med Chem, 2007; 50: 1988–1992
7.Yu L-F, Tückmantel W, Eaton JB, Caldarone B, Fedolak A, Hanania T, Brunner D, Lukas RJ, Kozikowski AP. Identification of novel α4β2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity. J Med Chem, 2012; 55: 812–823
8.Ye N, Zhu Y, Chen H, Liu Z, Mei FC, Wild C, Chen H, Cheng X, Zhou J. Structure-activity relationship studies of substituted 2-(isoxazol-3-yl)-2-oxo-N’-phenyl-acetohydrazonoyl cyanide analogues: identification of potent exchange proteins directly activated by cAMP (EPAC) antagonists. J Med Chem, 2015; 58: 6033–6047